The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration

[1]  B. R. Achyut,et al.  Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression , 2012, International journal of cancer.

[2]  P. Lance,et al.  Stromal COX-2 signaling activated by deoxycholic acid mediates proliferation and invasiveness of colorectal epithelial cancer cells. , 2012, Biochemical and biophysical research communications.

[3]  A. Fedenko,et al.  A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era , 2012, Sarcoma.

[4]  B. Fuchs,et al.  Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  Xiaodan Jiang,et al.  Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG , 2011, Cancer biology & therapy.

[6]  Long Yu,et al.  RLIM interacts with Smurf2 and promotes TGF-β induced U2OS cell migration. , 2011, Biochemical and biophysical research communications.

[7]  M. Szendrői,et al.  Good prognosis of localized osteosarcoma in young patients treated with limb‐salvage surgery and chemotherapy , 2011, Pediatric blood & cancer.

[8]  P. Barbry,et al.  CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  Peter F. M. Choong,et al.  The Molecular Pathogenesis of Osteosarcoma: A Review , 2011, Sarcoma.

[10]  D. Shen,et al.  RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells , 2011, Cancer Gene Therapy.

[11]  Zhong-ying Shen,et al.  Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. , 2010, The American journal of pathology.

[12]  R. Mirimanoff,et al.  CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. , 2008, Cancer research.

[13]  M Beth McCarville,et al.  Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma , 2008, Cancer.

[14]  Jing Qing,et al.  TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .

[15]  Xi C. He,et al.  Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. , 2007, Cancer research.

[16]  J. Chirgwin,et al.  The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. , 2007, Cancer letters.

[17]  A. Brivanlou,et al.  Dephosphorylation of the Linker Regions of Smad1 and Smad2/3 by Small C-terminal Domain Phosphatases Has Distinct Outcomes for Bone Morphogenetic Protein and Transforming Growth Factor-β Pathways* , 2006, Journal of Biological Chemistry.

[18]  R. Gorlick,et al.  Chemotherapy resistance in osteosarcoma: current challenges and future directions , 2006, Expert review of anticancer therapy.

[19]  E. Canalis,et al.  Expression and regulation of CCN genes in murine osteoblasts. , 2006, Bone.

[20]  King-Jen Chang,et al.  Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-κB/Cyclooxygenase-2 Signaling Pathway , 2005, Clinical Cancer Research.

[21]  L. Girard,et al.  Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. , 2005, Journal of the American College of Surgeons.

[22]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[23]  T. Ratliff.  TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[24]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[25]  B. Perbal.  CCN proteins: multifunctional signalling regulators , 2004, The Lancet.

[26]  Hiroyuki Aburatani,et al.  SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. , 2003, Cancer research.

[27]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[28]  J. Rosenbloom,et al.  Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. , 2003, European journal of biochemistry.

[29]  F. Lallemand,et al.  The Expression of novH in Adrenocortical Cells Is Down-regulated by TGFβ1 through c-Jun in a Smad-independent Manner* , 2002, The Journal of Biological Chemistry.

[30]  Ying E. Zhang,et al.  TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses , 2002 .

[31]  Jiahuai Han,et al.  Transforming Growth Factor-β Induces Collagenase-3 Expression by Human Gingival Fibroblasts via p38 Mitogen-activated Protein Kinase* , 1999, The Journal of Biological Chemistry.

[32]  D. Brigstock.  The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .

[33]  A. Atfi,et al.  Induction of Apoptosis by DPC4, a Transcriptional Factor Regulated by Transforming Growth Factor-β through Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) Signaling Pathway* , 1997, The Journal of Biological Chemistry.

[34]  R. Davis,et al.  Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.

[35]  M. Gebhardt,et al.  Expression of transforming growth factor‐beta (TGF‐β) receptors, TGF‐β1 and TGF‐β2 production and autocrine growth control in osteosarcoma cells , 1994 .

[36]  N. Jaffe.  Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication. , 2009, Cancer treatment and research.

[37]  Jing Qing,et al.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. , 2007, The EMBO journal.

[38]  D. Brigstock.  Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) , 2004, Angiogenesis.

[39]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[40]  Li J. Yu,et al.  TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. , 2002, The EMBO journal.

[41]  M. Gebhardt,et al.  Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells. , 1994, International journal of cancer.